Premium
Breathing Micelles for Combinatorial Treatment of Rheumatoid Arthritis
Author(s) -
Tao Siyue,
Cheng Jian,
Su Gai,
Li Dan,
Shen Zhiqiang,
Tao Fenghua,
You Tao,
Hu Jinming
Publication year - 2020
Publication title -
angewandte chemie
Language(s) - English
Resource type - Journals
eISSN - 1521-3757
pISSN - 0044-8249
DOI - 10.1002/ange.202010009
Subject(s) - chemistry , proinflammatory cytokine , exhalation , nitric oxide , nitric oxide synthase , rheumatoid arthritis , heme , heme oxygenase , arthritis , pharmacology , breathing , inhalation , biophysics , biochemistry , inflammation , immunology , medicine , biology , enzyme , organic chemistry , anesthesia
Breathing process involves inhalation and exhalation of different gases in animals. The gas exchange of the breathing process plays a critical role in maintaining the physiological functions of living organisms. Although artificial breathing materials exhibiting volume expansion and contraction upon alternate exposure to different gases have been well explored, those being able to realize the gas exchange remain elusive. Herein, we report breathing micelles (BM) capable of inhaling nitric oxide (NO) and exhaling carbon monoxide (CO), both of which are endogenous gaseous signaling molecules. We demonstrate that BM can simultaneously scavenge overproduced NO and attenuate proinflammatory cytokines in lipopolysaccharide (LPS)‐challenged macrophage cells. In vivo studies revealed that BM outperformed conventional nonsteroidal anti‐inflammatory drugs such as dexamethasone (Dexa) in treatment of rheumatoid arthritis (RA) in adjuvant‐induced arthritis (AIA) rats, likely due to the combinatorial effect of NO depletion, CO‐mediated deactivation of inducible NO synthase (iNOS) and activation of heme oxygenase‐1 (HO‐1). This work provides new insights into artificial BM for potential biomedical applications.